Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Markets
  • Options

Check Out What Whales Are Doing With CME

By Benzinga Insights
July 7, 4:23 PM
A whale with a lot of money to spend has taken a noticeably bullish stance on CME Group. Looking at options history for CME Group (NASDAQ:CME) we detected 12 strange trades.

CME

Read More
1 minute read
  • Analyst Ratings

12 Analysts Have This to Say About Coupa Software

By Benzinga Insights
July 7, 4:23 PM
Analysts have provided the following ratings for Coupa Software (NASDAQ:COUP) within the last quarter:

COUP

Read More
2 minute read
  • Markets
  • Options

Marathon Petroleum Whale Trades Spotted

By Benzinga Insights
July 7, 4:22 PM
A whale with a lot of money to spend has taken a noticeably bearish stance on Marathon Petroleum. Looking at options history for Marathon Petroleum (NYSE:MPC) we detected 13 strange trades.

MPC

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for Cerence

By Benzinga Insights
July 7, 4:22 PM
Cerence (NASDAQ:CRNC) has observed the following analyst ratings within the last quarter:

CRNC

Read More
2 minute read
  • News

Zomedica Announces New Global Manufacturing & Distribution Center In Georgia

By Michael Horton
July 7, 4:19 PM
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, is expanding its manufacturing and

ZOM

Read More
1 minute read
  • News

Mercury’s advanced encryptor receives certification from National Security Agency

By Michael Horton
July 7, 4:17 PM
Mercury Systems, Inc. (NASDAQ:MRCY,  , www.mrcy.com)))), a leader in trusted, secure mission-critical technologies for aerospace and defense, announced today that its Jannson Data-At-Rest (JDAR) encryptor has been

MRCY

Read More
1 minute read
  • Management
  • News

‘GameStop CFO out, layoffs across company, including at GameStop proper and Game Informer. Unclear how hard people have been hit but doesn’t sound small. “a number of reductions” as per company memo’ -Axios Reporter

By Benzinga Newsdesk
July 7, 4:15 PM
https://twitter.com/stephentotilo/status/1545137465748590593

GME

Read More
1 minute read
  • News

Ashford Hospitality Trust Says Expects To Report Occupancy Of ~73% For Q2’22 With ADR Of ~$184 Resulting In Revpar Of ~$134

By Michael Horton
July 7, 4:12 PM
-Reuters

AHT

Read More
4 minute read
  • M&A

The Oncology Institute Acquires The Practice Of Dr. Ranjan Sapra, Md

By Benzinga Newsdesk
July 7, 4:10 PM
The Oncology Institute Continues Southern California Expansion CERRITOS, Calif., July 07, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI), one of the largest value-based community oncology groups in

TOI

Read More
1 minute read
  • Earnings
  • News

Nurix Therapeutics Q2 EPS $(1.01) Down From $(0.60) YoY

By Bill Haddad
July 7, 4:09 PM
Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.

NRIX

Posts pagination

Previous 1 … 18,955 18,956 18,957 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service